featured
SGLT2 Inhibitors and Nephrolithiasis Risk Reduction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Nephrolithiasis
Diabetologia 2021 Jul 01;64(7)1563-1571, KB Kristensen, DP Henriksen, J Hallas, A Pottegård, LC LundFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.